Roche Asks Fed. Circ. To Revive Boniva Dosage Patents
Hoffmann-La Roche Inc. pushed a Federal Circuit panel on Friday to resurrect two of its patents covering the osteoporosis drug Boniva despite protests from several generic-drug makers, maintaining there was nothing...To view the full article, register now.
Already a subscriber? Click here to view full article